CAESARS ENTERTAINMENT INC (CZR) Fundamental Analysis & Valuation

NASDAQ:CZR • US12769G1004

Current stock price

27.1 USD
-0.33 (-1.2%)
Last:

This CZR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CZR Profitability Analysis

1.1 Basic Checks

  • CZR had negative earnings in the past year.
  • In the past year CZR had a positive cash flow from operations.
  • In the past 5 years CZR reported 4 times negative net income.
  • CZR had a positive operating cash flow in each of the past 5 years.
CZR Yearly Net Income VS EBIT VS OCF VS FCFCZR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • CZR's Return On Assets of -1.59% is on the low side compared to the rest of the industry. CZR is outperformed by 69.84% of its industry peers.
  • CZR's Return On Equity of -14.33% is in line compared to the rest of the industry. CZR outperforms 40.48% of its industry peers.
  • CZR's Return On Invested Capital of 5.59% is in line compared to the rest of the industry. CZR outperforms 53.17% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CZR is below the industry average of 10.59%.
Industry RankSector Rank
ROA -1.59%
ROE -14.33%
ROIC 5.59%
ROA(3y)-0.03%
ROA(5y)-1.09%
ROE(3y)-1.25%
ROE(5y)-10.14%
ROIC(3y)6.03%
ROIC(5y)5.39%
CZR Yearly ROA, ROE, ROICCZR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • CZR has a better Operating Margin (18.09%) than 77.78% of its industry peers.
  • CZR's Operating Margin has improved in the last couple of years.
  • CZR has a Gross Margin (47.20%) which is in line with its industry peers.
  • CZR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.09%
PM (TTM) N/A
GM 47.2%
OM growth 3Y1.7%
OM growth 5Y45.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y1.53%
CZR Yearly Profit, Operating, Gross MarginsCZR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

1

2. CZR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CZR is still creating some value.
  • The number of shares outstanding for CZR has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CZR has less shares outstanding
  • Compared to 1 year ago, CZR has a worse debt to assets ratio.
CZR Yearly Shares OutstandingCZR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CZR Yearly Total Debt VS Total AssetsCZR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • CZR has an Altman-Z score of 0.54. This is a bad value and indicates that CZR is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.54, CZR is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of CZR is 50.47, which is on the high side as it means it would take CZR, 50.47 years of fcf income to pay off all of its debts.
  • CZR has a Debt to FCF ratio of 50.47. This is in the lower half of the industry: CZR underperforms 61.11% of its industry peers.
  • A Debt/Equity ratio of 7.07 is on the high side and indicates that CZR has dependencies on debt financing.
  • The Debt to Equity ratio of CZR (7.07) is worse than 67.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.07
Debt/FCF 50.47
Altman-Z 0.54
ROIC/WACC1.12
WACC4.99%
CZR Yearly LT Debt VS Equity VS FCFCZR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B 25B

2.3 Liquidity

  • CZR has a Current Ratio of 0.80. This is a bad value and indicates that CZR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.80, CZR is doing worse than 62.70% of the companies in the same industry.
  • A Quick Ratio of 0.78 indicates that CZR may have some problems paying its short term obligations.
  • CZR's Quick ratio of 0.78 is on the low side compared to the rest of the industry. CZR is outperformed by 61.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.78
CZR Yearly Current Assets VS Current LiabilitesCZR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

4

3. CZR Growth Analysis

3.1 Past

  • The earnings per share for CZR have decreased strongly by -228.38% in the last year.
  • Looking at the last year, CZR shows a small growth in Revenue. The Revenue has grown by 2.14% in the last year.
  • CZR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.92% yearly.
EPS 1Y (TTM)-228.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2560%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y2.01%
Revenue growth 5Y25.92%
Sales Q2Q%4.18%

3.2 Future

  • CZR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.63% yearly.
  • CZR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.10% yearly.
EPS Next Y96.76%
EPS Next 2Y50.53%
EPS Next 3Y35.77%
EPS Next 5Y30.63%
Revenue Next Year2.79%
Revenue Next 2Y2.63%
Revenue Next 3Y2.53%
Revenue Next 5Y3.1%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CZR Yearly Revenue VS EstimatesCZR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B
CZR Yearly EPS VS EstimatesCZR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5 -10

3

4. CZR Valuation Analysis

4.1 Price/Earnings Ratio

  • CZR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CZR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CZR Price Earnings VS Forward Price EarningsCZR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

  • CZR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CZR is cheaper than 76.98% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CZR is valued cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.19
EV/EBITDA 8.46
CZR Per share dataCZR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

  • CZR's earnings are expected to grow with 35.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.53%
EPS Next 3Y35.77%

0

5. CZR Dividend Analysis

5.1 Amount

  • CZR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CZR Fundamentals: All Metrics, Ratios and Statistics

CAESARS ENTERTAINMENT INC

NASDAQ:CZR (3/19/2026, 11:45:03 AM)

27.1

-0.33 (-1.2%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-17
Earnings (Next)04-27
Inst Owners111.46%
Inst Owner Change2.92%
Ins Owners1.04%
Ins Owner Change3.54%
Market Cap5.52B
Revenue(TTM)11.49B
Net Income(TTM)-502.00M
Analysts76.8
Price Target34.26 (26.42%)
Short Float %15.38%
Short Ratio4.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-513.02%
Min EPS beat(2)-639.28%
Max EPS beat(2)-386.76%
EPS beat(4)0
Avg EPS beat(4)-533.78%
Min EPS beat(4)-925.61%
Max EPS beat(4)-183.48%
EPS beat(8)1
Avg EPS beat(8)-434.23%
EPS beat(12)2
Avg EPS beat(12)-1183.03%
EPS beat(16)3
Avg EPS beat(16)-932.06%
Revenue beat(2)0
Avg Revenue beat(2)-0.91%
Min Revenue beat(2)-1.78%
Max Revenue beat(2)-0.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.78%
Max Revenue beat(4)0.52%
Revenue beat(8)1
Avg Revenue beat(8)-1.66%
Revenue beat(12)3
Avg Revenue beat(12)-1.08%
Revenue beat(16)5
Avg Revenue beat(16)-0.89%
PT rev (1m)-4.63%
PT rev (3m)-5.14%
EPS NQ rev (1m)-55.2%
EPS NQ rev (3m)-127.36%
EPS NY rev (1m)-237.91%
EPS NY rev (3m)-124.39%
Revenue NQ rev (1m)-0.86%
Revenue NQ rev (3m)-1.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF 11.19
P/OCF 4.24
P/B 1.57
P/tB N/A
EV/EBITDA 8.46
EPS(TTM)-2.43
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)2.42
FCFY8.94%
OCF(TTM)6.4
OCFY23.61%
SpS56.44
BVpS17.22
TBVpS-53.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.59%
ROE -14.33%
ROCE 7.07%
ROIC 5.59%
ROICexc 5.76%
ROICexgc 11.67%
OM 18.09%
PM (TTM) N/A
GM 47.2%
FCFM 4.29%
ROA(3y)-0.03%
ROA(5y)-1.09%
ROE(3y)-1.25%
ROE(5y)-10.14%
ROIC(3y)6.03%
ROIC(5y)5.39%
ROICexc(3y)6.22%
ROICexc(5y)5.57%
ROICexgc(3y)12.71%
ROICexgc(5y)11.43%
ROCE(3y)7.63%
ROCE(5y)6.83%
ROICexgc growth 3Y3.82%
ROICexgc growth 5Y91.84%
ROICexc growth 3Y5.32%
ROICexc growth 5Y87.13%
OM growth 3Y1.7%
OM growth 5Y45.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y1.53%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 7.07
Debt/FCF 50.47
Debt/EBITDA 7.09
Cap/Depr 57.09%
Cap/Sales 7.04%
Interest Coverage 2.56
Cash Conversion 37.25%
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.78
Altman-Z 0.54
F-Score5
WACC4.99%
ROIC/WACC1.12
Cap/Depr(3y)86.24%
Cap/Depr(5y)82.51%
Cap/Sales(3y)9.98%
Cap/Sales(5y)9.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-228.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2560%
EPS Next Y96.76%
EPS Next 2Y50.53%
EPS Next 3Y35.77%
EPS Next 5Y30.63%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y2.01%
Revenue growth 5Y25.92%
Sales Q2Q%4.18%
Revenue Next Year2.79%
Revenue Next 2Y2.63%
Revenue Next 3Y2.53%
Revenue Next 5Y3.1%
EBIT growth 1Y-8.66%
EBIT growth 3Y3.74%
EBIT growth 5Y82.73%
EBIT Next Year82.3%
EBIT Next 3Y24.69%
EBIT Next 5Y17.36%
FCF growth 1Y308.9%
FCF growth 3Y245.06%
FCF growth 5YN/A
OCF growth 1Y21.12%
OCF growth 3Y10.12%
OCF growth 5YN/A

CAESARS ENTERTAINMENT INC / CZR Fundamental Analysis FAQ

What is the fundamental rating for CZR stock?

ChartMill assigns a fundamental rating of 2 / 10 to CZR.


What is the valuation status for CZR stock?

ChartMill assigns a valuation rating of 3 / 10 to CAESARS ENTERTAINMENT INC (CZR). This can be considered as Overvalued.


Can you provide the profitability details for CAESARS ENTERTAINMENT INC?

CAESARS ENTERTAINMENT INC (CZR) has a profitability rating of 3 / 10.


What is the expected EPS growth for CAESARS ENTERTAINMENT INC (CZR) stock?

The Earnings per Share (EPS) of CAESARS ENTERTAINMENT INC (CZR) is expected to grow by 96.76% in the next year.